Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats
Figure 10
The fructose levels in the lenses at 40 weeks. The fructose level in the untreated lenses is very low compared with other ARI-treated lenses. NDM: non-diabetes mellitus; DM: diabetes mellitus; rani: ranirestat; epa: epalrestat.